Erectile Dysfunction

Erectile Dysfunction News

AUA Avanafil Effective in Difficult-to-Treat ED Avanafil, a phosphodiesterase type 5 inhibitor, effectively reverses erectile dysfunction (ED) in difficult-to-treat patients.
Medscape Medical News, June 1, 2012
Alert New Erectile Dysfunction Drug Okayed by FDA Avanafil becomes the fifth FDA-approved oral drug for ED. It is taken on an as-needed basis 30 minutes before sexual activity.
FDA Approvals, April 27, 2012

LUTS: Another Good Reason for Tadalafil This F1000 commentary reports on a study whose findings support the effectiveness of tadalafil in treating lower urinary tract symptoms caused by benign prostatic hyperplasia.
Faculty of 1000, May 18, 2012
Repeated Exposure to ED Ads May Cause ED Andrew Vickers has uncovered a dubious study that found that watching too many ads on drugs for erectile dysfunction can lead to erectile dysfunction. With apologies to The Onion.
Medscape Business of Medicine, May 1, 2012

Lifestyle and Metabolic Effects on Erectile, Vascular Health
International Journal of Impotence Research, May 11, 2012
Inhibition of Smooth Muscle Tone for Erectile Dysfunction
International Journal of Impotence Research, April 11, 2012
Nerve-sparing Prostatectomy and Penile Oxygen Monitoring
International Journal of Impotence Research, February 22, 2012
Management of Sexual Dysfunction in Parkinson's Disease
Therapeutic Advances in Neurological Disorders, January 10, 2012
The Effect of Simvastatin in Penile Erection
International Journal of Impotence Research, December 2, 2011